Antiproliferative Activity of Polyether Antibiotic - Cinchona Alkaloid Conjugates Obtained via Click Chemistry

Chemical Biology and Drug Design

Volumn 86, Issue 4, 2015, Pages 911-917

  Skiera, Iwona ^a   Antoszczak, Michał ^a   Trynda, Justyna ^b   Wietrzyk, Joanna ^b   Boratyński, Przemysław ^c   Kacprzak, Karol ^a   Huczyński, Adam ^a  

^a ADAM MICKIEWICZ UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^c WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

anticancer activity; Cinchona alkaloids; click chemistry; monensin; salinomycin

Indexed keywords

9 AZIDO (9 DEOXY)EPIQUINIDINE; 9 AZIDO (9 DEOXY)EPIQUININE; 9 AZIDO (9 DEOXY)QUININE; 9 AZIDOMETHYLCINCHONINE; ANTINEOPLASTIC AGENT; CINCHONA ALKALOID; CISPLATIN; DOXORUBICIN; MONENSIN; POLYETHER ANTIBIOTIC AGENT; SALINOMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; PYRAN DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CLICK CHEMISTRY; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; EMBRYO; FIBROBLAST CULTURE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IC50; LIVER CANCER CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; NEOPLASMS; TUMOR CELL LINE;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CINCHONA ALKALOIDS; CLICK CHEMISTRY; HUMANS; MONENSIN; NEOPLASMS; PYRANS;

EID: 84942500080     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.12523     Document Type: Article

References (36)

1. Kalia J., Raines R.T., (2010) Advances in bioconjugation. Curr Org Chem; 14: 138-147.
2. Bosquesi P.L., Melo T.R.F., Vizioli E.O., Santos J.L., Chung M.C., (2011) Anti-inflammatory drug design using a molecular hybridization approach. Pharmaceuticals; 4: 1450-1474.
3. Rostovtsev V.V., Green L.G., Fokin V.V., Sharpless K.B., (2002) A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. Angew Chem Int Ed; 41: 2596-2599.
4. Tornoe C.W., Christensen C., Meldal M., (2002) Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J Org Chem; 67: 3057-3064.
5. Presolski S.I., Hong V.P., Finn M.G., (2011) Copper-catalyzed azide-alkyne click chemistry for bioconjugation. Curr Protoc Chem Biol; 3: 153-162.
6. Hein J.E., Fokin V.V., (2010) Copper-catalyzed azide-alkyne cycloaddition (CuAAC) and beyond: new reactivity of copper(I) acetylides. Chem Soc Rev; 39: 1302-1315.
7. Agalave S.G., Maujan S.R., Pore V.S., (2011) Click chemistry: 1,2,3-triazoles as pharmacophores. Chem Asian J; 6: 2696-2718.
8. Kevin D.A. II, Meujo D.A.F., Hamann M.T., (2009) Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites. Exp Opin Drug Discov; 4: 109-146.
9. Huczyński A., (2012) Polyether ionophores-promising bioactive molecules for cancer therapy. Bioorg Med Chem Lett; 22: 7002-7010.
10. Gupta P.B., Onder T.T., Jiang G., Tao K., Kuperwasser C., Weinberg R.A., Lander E.S., (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell; 138: 645-659.
11. Koo K.H., Kim H., Bae Y.K., Kim K., Park B.K., Lee C.H., Kim Y.N., (2013) Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2. Cell Death Dis; 4: e693.
12. Zhu L.Q., Zhen Y.F., Zhang Y., Guo Z.X., Dai J., Wang X.D., (2013) Salinomycin activates AMP-activated protein kinase-dependent autophagy in cultured osteoblastoma cells: a negative regulator against cell apoptosis. PLoS ONE; 8: e84175.
13. Klose J., Stankov M.V., Kleine M., Ramackers W., Panayotova-Dimitrova D., Jäger M.D., Klempnauer J., Winkler M., Bektas H., Behrens G.M.N., Vondran F.W.R., (2014) Inhibition of autophagic flux by salinomycin results in anti-cancer effect in hepatocellular carcinoma cells. PLoS ONE; 9: e95970.
14. Wang F., Dai W., Wang Y., Shen M., Chen K., Cheng P., Zhang Y., et al., (2014) The synergistic in vitro and in vivo antitumor effect of combination therapy with salinomycin and 5-fluorouracil against hepatocellular carcinoma. PLoS ONE; 9: e97414.
15. Calzolari A., Saulle E., De Angelis M.L., Pasquini L., Boe A., Pelacchi F., Ricci-Vitiani L., Baiocchi M., Testa U., (2014) Salinomycin potentiates the cytotoxic effects of TRAIL on glioblastoma cell lines. PLoS ONE; 9: e94438.
16. Park W.H., Kim E.S., Jung C.W., Kim B.K., Lee Y.Y., (2003) Monensin-mediated growth inhibition of SNU-C1 colon cancer cells via cell cycle arrest and apoptosis. Int J Oncol; 22: 377-382.
17. Park W.H., Seol J.G., Kim E.S., Kang W.K., Im Y.H., Jung C.W., Kim B.K., Lee Y.Y., (2002) Monensin-mediated growth inhibition in human lymphoma cells through cell cycle arrest and apoptosis. Br J Haematol; 119: 400-407.
18. Park W.H., Kim E.S., Kim B.K., Lee Y.Y., (2003) Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apotosis. Int J Oncol; 23: 197-204.
19. Ketola K., Vainio P., Fey V., Kallioniemi O., Iljin K., (2010) Monensin is a potent inducer of oxidative stress and inhibitor of androgen signaling leading to apoptosis in prostate cancer cells. Mol Cancer Ther; 9: 3175-3185.
20. Wood D.J., Rumsby M.G., Warr J.R., (1996) Monensin and verapamil do not alter intracellular localization of daunorubicin in multidrug resistant human KB cells. Cancer Lett; 108: 41-47.
21. Kacprzak K., (2013) Chemistry and biology of Cinchona alkaloids. In:, Ramawat K.G., Merillon J.M., editors. Handbook of Natural Products-Phytochemistry, Botany, Metabolism. Heidelberg: Springer Berlin; p. 605-641.
22. Martirosyan A.R., Rahim-Bata R., Freeman A.B., Clarke C.D., Howard R.L., Strobl J.S., (2004) Differentiation-inducing quinolines as experimental breast cancer agents in the MCF-7 human breast cancer cell model. Biochem Pharmacol; 68: 1729-1738.
23. Solary E., Mannone L., Moreau D., Caillot D., Casasnovas R.O., Guy H., Grandjean M., Wolf J.E., André F., Fenaux P., Canal P., Chauffert B., Wotawa A., Bayssas M., Genne P., (2000) Phase I study of cinchonine, a multidrug resistance reversing agent, combined with CHVP regimen in relapsed and refractory lymphoproliferative syndromes. Leukemia; 14: 2085-2094.
24. Pires M.M., Emmert D., Hrycyna C.A., Chmielewski J., (2009) Inhibition of P-glycoprotein-mediated paclitaxel resistance by reversibly linked quinine homodimers. Mol Pharmacol; 75: 92-100.
25. Baraniak D., Kacprzak K., Celewicz L., (2011) Synthesis of 3′-azido-3′-deoxythymidine (AZT)-Cinchona alkaloid conjugates via click chemistry: toward novel fluorescent markers and cytostatic agent. Bioorg Med Chem Lett; 21: 723-726.
26. Kacprzak K., Gierczyk B., (2010) Clickable 9-azido-(9-deoxy)-Cinchona alkaloids: synthesis and conformation. Tetrahedron Asymmetry; 21: 2740-2745.
27. Kacprzak K., Migas M., Plutecka A., Rychlewska U., Gawronski J., (2005) The library of Cinchona alkaloids-1,2,3-triazole derivatives: structure and facile access by "click chemistry". Heterocycles; 65: 1931-1938.
28. Boratyński P.J., Skarzewski J.J., (2013) Diastereoselective Corey-Chaykovsky 9-epoxymethylation of Cinchona alkaloids: access to chiral scaffolds with diverse functionalities. J Org Chem; 78: 4473-4482.
29. Huczyński A., Janczak J., Antoszczak M., Stefańska J., Brzezinski B., (2012) X-ray, FT-IR, NMR and PM5 structural studies and antibacterial activity of unexpectedly stable salinomycin-benzotriazole intermediate ester. J Mol Struct; 1022: 197-203.
30. Huczyński A., Janczak J., Stefańska J., Antoszczak M., Brzezinski B., (2012) Synthesis and antimicrobial activity of amide derivatives of polyether antibiotic-salinomycin. Bioorg Med Chem Lett; 22: 4697-4702.
31. Huczyński A., Janczak J., Antoszczak M., Wietrzyk J., Maj E., Brzezinski B., (2012) Antiproliferative activity of salinomycin and its derivatives. Bioorg Med Chem Lett; 22: 7146-7150.
32. Antoszczak M., Maj E., Stefańska J., Wietrzyk J., Janczak J., Brzezinski B., Huczyński A., (2014) Synthesis, antiproliferative and antibacterial activity of new amides of salinomycin. Bioorg Med Chem Lett; 24: 1724-1729.
33. Antoszczak M., Popiel K., Stefańska J., Wietrzyk J., Maj E., Janczak J., Michalska G., Brzezinski B., Huczyński A., (2014) Synthesis, cytotoxicity and antibacterial activity of new esters of polyether antibiotic-salinomycin. Eur J Med Chem; 76: 435-444.
34. + exchanger activity is increased in doxorubicin-resistant human colon cancer cells and its modulation modifies the sensitivity of the cells to doxorubicin. Int J Cancer; 115: 924-929.
35. Riccioni R., Dupuis M.L., Bernabei M., Petrucci E., Pasquini L., Mariani G., Cianfriglia M., Testa U., (2010) The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor. Blood Cells Mol Dis; 45: 86-92.
36. Altan N., Chen Y., Schindler M., Simon S.M., (1998) Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med; 187: 1583-1598.